Therapeutic drug monitoring of antifungal agents

被引：1

作者：

Lewis J.S., II ^{[1
]}

机构：

[1] Inpatient Pharmacy, University Health System, 4502 Medical Drive, San Antonio, 782229, TX

来源：

Current Fungal Infection Reports | 2009年 / 3卷 / 2期

关键词：

Voriconazole; Invasive Aspergillosis; Antimicrob Agent; Posaconazole; Hematopoietic Stem Cell Transplant Recipient;

D O I：

10.1007/s12281-009-0013-y

中图分类号：

学科分类号：

摘要：

Despite a dramatic increase in the number of commercially available agents to treat invasive fungal infections, they remain a common and devastating problem in a variety of patients. The impact of these infections has furthered interest in optimizing antifungal therapy. Therapeutic drug monitoring has emerged as a potentially important area allowing the efficacy of select antifungals to be optimized. This article reviews emerging data examining the utility and rationale for voriconazole and posaconazole therapeutic drug monitoring. © 2009 Current Medicine Group, LLC.

引用

页码：96 / 102

页数：6

共 50 条

[1] Therapeutic drug monitoring of antifungal agents
Heinz, Werner J.
Klinker, Hartwig
[J]. LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2012, 36 (02): : 99 - 109
[2] Antifungal therapeutic drug monitoring
Lewis R.E.
[J]. Current Fungal Infection Reports, 2010, 4 (3) : 158 - 167
[3] Update on antifungal drug dosing and therapeutic drug monitoring
Trifilio S.
[J]. Current Fungal Infection Reports, 2011, 5 (2) : 92 - 102
[4] Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients
John, Jamie
Loo, Angela
Mazur, Shawn
Walsh, Thomas J.
[J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (11) : 881 - 895
[5] Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization
Scodavolpe, Simon
Quaranta, Sylvie
Lacarelle, Bruno
Solas, Caroline
[J]. ANNALES DE BIOLOGIE CLINIQUE, 2014, 72 (04) : 391 - 404
[6] Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?
Baracaldo-Santamaria, Daniela
Cala-Garcia, Juan David
Medina-Rincon, German Jose
Rojas-Rodriguez, Luis Carlos
Calderon-Ospina, Carlos-Alberto
[J]. ANTIBIOTICS-BASEL, 2022, 11 (05):
[7] Antifungal Drug Therapeutic Monitoring: What are the Issues?
Myers E.
Dodds Ashley E.
[J]. Current Clinical Microbiology Reports, 2015, 2 (2) : 55 - 66
[8] Therapeutic drug monitoring of systemic antifungal therapy
Summers, KK
Hardin, TC
Gore, SJ
Graybill, JR
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (06) : 753 - 764
[9] Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
Ashbee, H. Ruth
Barnes, Rosemary A.
Johnson, Elizabeth M.
Richardson, Malcolm D.
Gorton, Rebecca
Hope, William W.
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (05) : 1162 - 1176
[10] Therapeutic drug monitoring of immunosuppressive agents
Sawe, J
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 354 (04) : 70 - 70

← 1 2 3 4 5 →